Final Analysis of the Phase I/II Study of CC-486 (Oral Azacitidine) Maintenance Therapy after Allogeneic Stem Cell Transplantation (Allo-SCT) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
暂无分享,去创建一个
C. Craddock | B. Skikne | R. Champlin | S. Giralt | B. Oran | B. Scott | B. William | E. Papadopoulos | J. Hetzer | B. Hubbell | M. Lima